|
gptkbp:instanceOf
|
gptkb:drug
gptkb:insulin
|
|
gptkbp:administeredBy
|
subcutaneous injection
|
|
gptkbp:approvalYear
|
1996
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
gptkb:A10AB04
|
|
gptkbp:CASNumber
|
133107-64-9
|
|
gptkbp:chemicalFormula
|
C257H383N65O77S6
|
|
gptkbp:contraindication
|
hypersensitivity to insulin lispro
|
|
gptkbp:duration
|
2 to 4 hours
|
|
gptkbp:form
|
solution for injection
|
|
gptkbp:genericName
|
gptkb:insulin
|
|
gptkbp:halfLife
|
about 1 hour
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Humalog
|
|
gptkbp:legalStatus
|
Rx-only (US)
|
|
gptkbp:manufacturer
|
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:marketedAs
|
gptkb:KwikPen
cartridge
vial
|
|
gptkbp:mechanismOfAction
|
lowers blood glucose by stimulating peripheral glucose uptake
|
|
gptkbp:onset
|
about 15 minutes
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:routeOfAdministration
|
subcutaneous
intravenous
|
|
gptkbp:sideEffect
|
gptkb:hypoglycemia
allergic reaction
lipodystrophy
|
|
gptkbp:type
|
rapid-acting insulin
|
|
gptkbp:usedFor
|
gptkb:diabetes_mellitus
|
|
gptkbp:bfsParent
|
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:bfsLayer
|
5
|